Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT06874634
Eligibility Criteria:
Inclusion Criteria:
* Patients admitted to the Intensive Care Department of Southern Hospital of Southern Medical University from September 2017 to June 2022;
Age ≥ 18 years old;
Meeting the diagnostic criteria for abdominal infection;
Patients who meet the diagnostic criteria for sepsis/septic shock;
Complicated with hypoalbuminemia, i.e. plasma albumin\<30g/L after admission;
Human serum albumin injection was infused within 24 hours after check-in into the ICU.
Exclusion Criteria:
* Pregnant or lactating women
Patients who have not been able to obtain relevant diagnosis and treatment information after ICU check-in
Patients who repeatedly stay in the ICU
ICU hospitalization time is less than 24 hours
Pathological conditions that require albumin treatment in clinical practice (cirrhosis with ascites, post liver transplantation, intestinal malabsorption syndrome, nephrotic syndrome, burns);
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT06874634
Study Brief:
Protocol Section:
NCT06874634